Arlington Scientific Revenue and Competitors

Springville, UT

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Arlington Scientific's estimated annual revenue is currently $11M per year.(i)
  • Arlington Scientific's estimated revenue per employee is $251,000

Employee Data

  • Arlington Scientific has 44 Employees.(i)
  • Arlington Scientific grew their employee count by 10% last year.

Arlington Scientific's People

NameTitleEmail/Phone
1
EVP Operations/ComplianceReveal Email/Phone
2
EVP RevenueReveal Email/Phone
3
Technical Production ManagerReveal Email/Phone
4
Purchasing/Customer Service ManagerReveal Email/Phone
5
Marketing ManagerReveal Email/Phone
6
Distribution Channel ManagerReveal Email/Phone
7
PresidentReveal Email/Phone
8
National Account Sales ExecutiveReveal Email/Phone
9
Operations SpecialistReveal Email/Phone
10
Research Analytical ChemistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$77.6M30928%N/AN/A
#2
$13.8M55-17%N/AN/A
#3
$397.8M15857%N/AN/A
#4
$35.9M14315%N/AN/A
#5
$75M15743%$12.8MN/A
#6
$6.5M260%N/AN/A
#7
$9.3M379%N/AN/A
#8
$37.4M149-1%N/AN/A
#9
$143.1M5709%N/AN/A
#10
$10.3M41-15%N/AN/A
Add Company

What Is Arlington Scientific?

Arlington Scientific, Inc® (ASI) is a USA based industry leading global medical technology company that develops, manufactures, and sells in-vitro diagnostics, diagnostic analyzers for syphilis screening, face shields, medical donor lounges for Apheresis and Blood Donor Collection, and nasal curettes for rapid viral testing. Arlington Scientific’s expertise and emphasis are in diagnostic syphilis reagents and serological test kits. Arlington Scientific developed the ASI Evolution, the only automated nontreponemal (RPR) syphilis analyzer FDA cleared for diagnostic and blood donor screening. ASI is an FDA registered establishment with 35 years of medical device manufacturing expertise. ASI shows industry leadership as the first to develop a nontreponemal algorithm for the detection of syphilis. The first to receive FDA clearance for a syphilis analyzer used for cadaveric tissue donor screening. Other industry firsts include developing mercury free RPR reagents, implementation of liquid controls, screw cap lids, warp resistant test cards, extended shelf life for reagents and developing in-vitro diagnostic RPR tests for use with CPD and CPDA-1 anticoagulants. ASI is committed to being a progressive industry leader through our pursuit of quality products, superior customer service, high corporate values, and a genuine appreciation for each customer. CR1964

keywords:N/A

N/A

Total Funding

44

Number of Employees

$11M

Revenue (est)

10%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$10.7M467%N/A
#2
$1.7M487%N/A
#3
$8.2M506%N/A
#4
$7.5M50-2%N/A
#5
$3.5M509%N/A